AroCell AB (AROC) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.010x

Based on the latest financial reports, AroCell AB (AROC) has a cash flow conversion efficiency ratio of -0.010x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.11 Million ≈ $-119.67K USD) by net assets (Skr108.87 Million ≈ $11.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AROC net asset quality index to measure how much of total assets are equity-financed.

AroCell AB - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how AroCell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AROC total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

AroCell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AroCell AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Integra Essentia Limited NSE:ESSENTIA	-0.210x
Maha Rashtra Apex Corporation Limited NSE:MAHAPEXLTD	-0.003x
Ihlas Yayin Holding A.S. IS:IHYAY	0.011x
Stockwik Forvaltning AB ST:STWK	-0.096x
Phoenix Materials Co. Ltd KQ:050090	-0.010x
Melbana Energy Ltd AU:MAY	-0.017x
Mynd.ai, Inc. NYSE MKT:MYND	-0.360x
Future Retail Limited NSE:FRETAIL	1.043x

Annual Cash Flow Conversion Efficiency for AroCell AB (2011–2024)

The table below shows the annual cash flow conversion efficiency of AroCell AB from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see AroCell AB market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr121.20 Million ≈ $13.04 Million	Skr-2.36 Million ≈ $-253.76K	-0.019x	+76.30%
2023-12-31	Skr163.65 Million ≈ $17.61 Million	Skr-13.44 Million ≈ $-1.45 Million	-0.082x	-33.52%
2022-12-31	Skr222.69 Million ≈ $23.97 Million	Skr-13.69 Million ≈ $-1.47 Million	-0.061x	+52.59%
2021-12-31	Skr217.45 Million ≈ $23.40 Million	Skr-28.21 Million ≈ $-3.04 Million	-0.130x	+61.39%
2020-12-31	Skr56.26 Million ≈ $6.05 Million	Skr-18.90 Million ≈ $-2.03 Million	-0.336x	-79.44%
2019-12-31	Skr80.41 Million ≈ $8.65 Million	Skr-15.06 Million ≈ $-1.62 Million	-0.187x	+37.79%
2018-12-31	Skr54.51 Million ≈ $5.87 Million	Skr-16.41 Million ≈ $-1.77 Million	-0.301x	+7.78%
2017-12-31	Skr46.68 Million ≈ $5.02 Million	Skr-15.24 Million ≈ $-1.64 Million	-0.326x	-188.96%
2016-12-31	Skr63.46 Million ≈ $6.83 Million	Skr-7.17 Million ≈ $-771.34K	-0.113x	+10.05%
2015-12-31	Skr72.69 Million ≈ $7.82 Million	Skr-9.13 Million ≈ $-982.27K	-0.126x	+76.77%
2011-12-31	Skr4.80 Million ≈ $516.22K	Skr-2.59 Million ≈ $-279.05K	-0.541x	--

About AroCell AB

ST:AROC Sweden Diagnostics & Research

Market Cap

$13.39 Million

Skr124.39 Million SEK

Market Cap Rank

#26318 Global

#557 in Sweden

Share Price

Skr0.54

Change (1 day)

+1.12%

52-Week Range

Skr0.53 - Skr0.54

All Time High

Skr15.05